Strategic Corporate Social Responsibility and Orphan Drug Development: Insights from the US and the EU Biopharmaceutical Industry O Bruyaka, HK Zeitzmann, I Chalamon, RE Wokutch, P Thakur Journal of Business Ethics 117 (1), 45-65, 2013 | 64 | 2013 |
Negative Denominators in Index Variables: The Vulnerability of Return on Equity, Debt to Equity, and Other Ratios DB Thornblad, HK Zeitzmann, KD Carlson Electronic Journal of Business Research Methods 16 (1), 1-10, 2018 | 9 | 2018 |
Add artifact control variables last in hierarchical regression analyses K Carlson, HK Zeitzmann, J Flynn Academy of Management Proceedings 2012 (1), 16952, 2012 | 5 | 2012 |
Social Entrepreneurship in Cross-Sectoral Collaborations Promoting Energy Efficiency HK Zeitzmann, JJ Jay, RE Wokutch, JA Johansen Journal of Ethics & Entrepreneurship 4 (2), 69-103, 2014 | | 2014 |
A Model of Non-Routine Organizational Search: Broadcast Search as an Alternative Knowledge-Sourcing Mechanism in the Pharmaceutical Industry. HK Zeitzmann Virginia Tech, 2013 | | 2013 |
Construct Validity Issues with Negative Denominator Ratios D Thornblad, HK Zeitzmann Academy of Management Proceedings 2013 (1), 16257, 2013 | | 2013 |